Access cutting-edge sjögren's syndrome treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access sjögren's syndrome specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sjögren's syndrome treatment provided free
The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
Sponsor: Bristol-Myers Squibb
Check if you qualify for this sjögren's syndrome clinical trial in San Francisco, CA
If you're searching for sjögren's syndrome treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sjögren's syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.